Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may ...

In his March 2023 budget, the then UK Chancellor, Jeremy Hunt, accordingly announced that from 2024 the Medicines and ...

It is the only example globally of an end-to-end access pathway, where a medicine developer can work collaboratively with the ...

Esther McVey said there was a ‘gross underreporting’ of unintended impacts of vaccines to the medicines regulator.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a suite of guidance specifically designed to help medical ...

The charity has described the UK medicine regulator’s decision not to approve Syfovre as “undoubtedly disappointing news” ...

The MHRA has issued fresh guidance to help medical device manufacturers prepare for upcoming regulatory changes.

Patients do not need to return the products but have been advised to 'be vigilant for any visible contamination and contact a ...